AI and blockchain will counteract unsustainability of soaring drug prices
The role of Robomed Network in increasing capacity to delve into big data, identify patterns, and generate algorithms to explain them was examined in an article published by APBN (Asia Pacific Biotech News) magazine.
The text refers to the worlds of Valentina Gburcik, PhD, Cardiovascular and Metabolic Disease Director at GlobalData. “Robomed Network represents one of the early decentralized platforms that mark a new era of the intersection between blockchain and the healthcare space. It provides cost-effective medical care through its smart contract, a digital token system of healthcare service providers and patients”.
Read more at https://www.asiabiotech.com/22/2205/22050039x.html
